Physician
Brodnax, Jean
Brodnax, Jean was paid $783K by Medicaid between Mar 2018 and Mar 2023, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoBRODNAX, JEAN
BRAINTREE, MA 02184
BRAINTREE, MA 02184
33aNPI1134117096assigned 10/13/2005
33bProvider typePediatrics Physician
28Total paid$783K
24GClaims12,170
24DCodes billed23
24AFirst – last monthMar 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#98 of 1,273
Median peer was paid$24K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,429 | $209K | |
| 2019 | 3,460 | $140K | |
| 2020 | 3,818 | $219K | |
| 2021 | 1,465 | $123K | |
| 2022 | 941 | $82K | |
| 2023 | 57 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 3,359 | 3,240 | $317K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 707 | 693 | $130K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.3% | 944 | 927 | $73K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.1% | 717 | 703 | $40K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.8% | 1,113 | 601 | $37K |
| 99051 | 4.6% | 1,497 | 1,453 | $36K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.3% | 221 | 221 | $34K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.2% | 242 | 242 | $33K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.2% | 563 | 560 | $17K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 117 | 117 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 581 | 579 | $12K |
| 90461 | 1.2% | 586 | 193 | $10K |
11 more codes
| 96127 | 1.2% | 499 | $9K | |
| 87081 | <1% | 490 | $5K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 161 | $4K |
| 98966 | <1% | 187 | $3K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 30 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 70 | $2K |
| 99442 | <1% | 12 | $377.04 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27 | $374.37 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $370.68 |
| 99441 | <1% | 22 | $357.72 | |
| 85027 | <1% | 13 | $199.42 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.